首页|参麦通脉汤治疗脾肾阳虚型低血压的药理机制研究

参麦通脉汤治疗脾肾阳虚型低血压的药理机制研究

扫码查看
目的 探究参麦通脉汤治疗脾肾阳虚型低血压的药理机制。方法 选取从 2022 年 11 月~2023 年 5 月期间天津市中医药研究院附属医院收治的脾肾阳虚型低血压患者 60 例,按照随机数表法将其分为治疗组和对照组,各 30 例。对照组使用盐酸米多君片进行基础治疗,研究组在对照组基础上联合参麦通脉汤进行治疗,比较两组患者的血压变化情况、血流动力学变化、心功能指标。结果 治疗组总有效率为 96。67%,高于对照组 73。33%,差异有统计学意义(P<0。05)。治疗后,两组收缩压和舒张压均升高,其中治疗组患者比对照组患者收缩压和舒张压升高更加显著,差异有统计学意义(P<0。05)。治疗组患者与治疗前相比,心排血量(CO)、心脏指数(CI)和射血分数(EF)升高,差异有统计学意义(P<0。05)。治疗后两组左心室舒张末期内径(LVEDd)降低,左心室射血分数(LVEF)值升高,治疗组LVEDd小于对照组,治疗组LVEF高于对照组,差异有统计学意义(P<0。05)。结论 参麦通脉汤通过增加冠脉流量的方式改善心肌缺血,并且能够增强心肌收缩力,降低心肌耗氧量,提高心排血量、心脏指数和射血分数,改善心功能,从而达到治疗脾肾阳虚型低血压的目的并且效果显著。
Study on pharmacological mechanism of Shenmai Tongmai Decoction in treating spleen-kidney Yang deficiency type hypotension
Objective To explore the pharmacological mechanism of Shenmai Tongmai Decoction in treating spleen-kidney Yang deficiency type hypotension.Methods A total of 60 patients with spleen-kidney Yang deficiency type hypotension admitted to the Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine from November 2022 to May 2023 were selected and divided into the treatment group and the control group with 30 cases in each group according to random number table method.The control group received basic treatment with midodrine hydrochloride tablet,on the basic of control group,the study group combined with Shenmai Tongmai Decoction treatment.Blood pressure changes,hemodynamic changes,cardiac function indexes were compared between the two groups.Results The total effective rate of the treatment group was 96.67%,which was higher than that of the control group by 73.33%,and the difference was statistically significant(P<0.05).After treatment,both systolic and diastolic blood pressure were increased in the two groups,and the systolic and diastolic blood pressure in the treatment group was significantly higher than that in the control group,with statistical significance(P<0.05).Cardiac output(CO),cardiac index(CI)and ejection fraction(EF)were increased in the treatment group compared with those before treatment,with statistical significance(P<0.05).After treatment,left ventricular end-diastolic diameter(LVEDd)decreased and left ventricular ejection fraction(LVEF)increased in both groups.LVEDd in treatment group was lower than that in control group,and LVEF in treatment group was higher than that in control group,with statistical significance(P<0.05).Con-clusion Shenmai Tongmai Decoction can improve myocardial ischemia by increasing coronary artery flow,and can enhance myocardial contractile force,reduce myocardial oxygen consumption,increase cardiac output,heart index and ejection fraction,and improve cardiac function,so as to achieve the purpose of treating spleen-kidney Yang deficiency type hypotension and the effect is significant.

Shenmai Tongmai DecoctionSpleen-kidney Yang deficiency typeHypotensionPharmacological mechanism

王丽霞、王晓霞、李亚莉、张澜艺

展开 >

天津市中医药研究院附属医院急重症医学科,天津 300131

天津市中医药研究院附属医院脑病三科,天津 300131

参麦通脉汤 脾肾阳虚型 低血压 药理机制

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(6)